Exome Asset Management’s Merus MRUS Stock Holding History

Exome Asset Management’s Portfolio MRUS Stock Details MRUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-45,100	Closed	-$2.67M	–	75
2024 Q2	$2.67M	Buy	+45,100	New	+$2.18M	2.38%	19

Other funds holding MRUS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Exome Asset Management's MRUS Position: Q3 2024 in Review

Exome Asset Management sold out of Merus (MRUS) in Q3 2024, closing a stake of 45,100 shares — an estimated $2.67M sold.

Exome Asset Management first reported a position in MRUS in Q2 2024 and held it in 1 quarter. The position peaked at $2.67M in Q2 2024. 189 funds tracked by Wall St. Rank hold MRUS as of Q3 2024.

Exome Asset Management reported no remaining Merus position as of Q3 2024 after selling out during the quarter.
Exome Asset Management sold 45,100 Merus shares in Q3 2024, an estimated $2.67M.
Exome Asset Management first reported a position in Merus in Q2 2024 and held it in 1 quarter.
Exome Asset Management's Merus position peaked at $2.67M in Q2 2024.
189 funds tracked by Wall St. Rank held Merus as of Q3 2024.

Based on Exome Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.